glp 1 and liver enzymes Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH Frontiers | Future Perspectives on
Description
An international consensus now defines MAFLD through steatosis and diabetes/obesity or two metabolic abnormalities
They revealed that the glucagon precursor gene encoded additional peptides beyond glucagon [6,7]
Pharmaceutics , 17 (8), 1036
About 18% took either medication specifically for obesity
